← Open Payments lookup

THOMAS LUCAS: Open Payments

NPI 1568411411 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,983 in 135 payments from 22 companies in 2025. Trend: 2023 $2,813 · 2024 $2,211 · 2025 $2,983

Food & beverage: $2,833Consulting: $150
CompanyPaymentsAmount
ABBVIE INC.28$405
Corium, LLC11$292
Axsome Therapeutics, Inc.10$291
Alkermes, Inc.11$288
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$263
Otsuka America Pharmaceutical, Inc.15$187
Teva Pharmaceuticals USA, Inc.7$180
Supernus Pharmaceuticals, Inc.9$179
Lundbeck LLC6$162
JAZZ PHARMACEUTICALS INC.1$150

Products named: VRAYLAR, REXULTI, Azstarys, Auvelity, CAPLYTA, ARISTADA, AUSTEDO XR, Qelbree.

Industry payments across TX — which companies pay providers there.